Table 1. BoNT/A1 neutralization activity of crude ascite fluids from 14 mAbs in the mouse protection assay (5 estimated MLD50/mouse).
Epitopic group | Antibody | Isotype | Protective titer |
A | TA2 | IgG1 | 104 |
TA10 | IgG1 | 103 | |
TA11 | IgG1 | 104 | |
TA12 | IgG1 | 105 | |
TA14 | IgG1 | 104 | |
B | TA4 | IgG2a | 104 |
TA7 | IgG2a | 104 | |
TA13 | IgG2a | 103 | |
TA17 | IgG2a | 104 | |
C | TA1 | IgG1 | ≤102 |
TA5 | IgG1 | ≤102 | |
TA15 | IgG1 | ≤102 | |
D | TA9 | IgG1 | 102 |
E | TA16 | IgG1 | 103 |
The protective titer is the highest dilution of the ascitic fluid that completely protected against 5 estimated MLD50 of BoNT/A1 in the mouse protection assay.
Underline: non-neutralizing antibodies. Three ml of 10 estimated MLD50/ml BoNT/A1 were incubated with 30 µl of serial ten-fold dilutions of ascitic fluid for 30 min at room temperature. 500 µl of the mixtures were injected intraperitoneally to give final toxin challenges of approximately 5 MLD/50 into each mouse of a group of 4 for each dilution.